Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03717584 · ClinicalTrials.gov registry record
A Cohort Study of the Intestinal Microbiota of Premature Infants
A clinical trial of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, sponsored by University of California, Davis.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT03717584: Active study of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, sponsored by University of California, Davis.
NCT03717584 is a study of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 300 participants, above the 226-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03717584, a study of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Premature infants are at risk for a variety of diseases, the investigators would like to learn more about why some premature babies are at higher risk and some are protected from these diseases. Scientists at UC Davis and other universities have developed new ways to measure the bacteria and a large number of small molecules in specimens of infant blood, urine, stomach fluid and poop and in mother's milk. These discoveries allow us to consider questions that were impossible to answer before these new techniques were developed. One such question is whether the bacteria in the poop of a premature baby can help us predict the baby's risk for developing infection or a common and serious disease of premature infants called necrotizing enterocolitis. A second question is whether the DNA of a premature baby (obtained from saliva with a q-tip) can predict higher risk for diseases of premature babies.
Primary Outcome
How many infants in the cohort develop stage 2 or stage 3 necrotizing enterocolitis by Bells modified criteria
Conditions Studied
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-12-23 |
| Est. Completion | 2027-03-05 |
What the registry record for NCT03717584 still lists
NCT03717584 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 226-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (33% higher).
The record links to 3 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT03717584 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03717584 about?
NCT03717584 is a clinical study titled "A Cohort Study of the Intestinal Microbiota of Premature Infants". Premature infants are at risk for a variety of diseases, the investigators would like to learn more about why some premature babies are at higher risk and some are protected from these diseases. Scientists at UC Davis and other universities have developed new ways to measure the bacteria and a larg...
What is the current status of trial NCT03717584?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2018-12-23. Estimated completion is 2027-03-05.
What conditions does trial NCT03717584 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Growth Failure.
Who is sponsoring clinical trial NCT03717584?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03717584 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03717584's enrollment target sits among peer trials
300 9th of 29 higher than 21 of 29 other Bronchopulmonary Dysplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI